The Latest Analyst Ratings For Molina Healthcare
Portfolio Pulse from Benzinga Insights
Recent analyst evaluations of Molina Healthcare (NYSE:MOH) show diverse opinions, with the latest average 12-month price target being $433.67, an 8.69% increase from the previous target. Analysts' ratings range from 'Underperform' to 'Overweight', reflecting varied expectations for the company's performance. Molina Healthcare's financial overview indicates a strong market position with notable revenue growth, net margin, ROE, and ROA, despite a high debt-to-equity ratio.
March 28, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Molina Healthcare's recent analyst evaluations and financial performance indicate a strong market position, with an updated average 12-month price target of $433.67, reflecting an 8.69% increase.
The increase in the average 12-month price target for MOH, along with diverse analyst ratings, suggests optimism about the company's future performance. The financial overview, highlighting strong revenue growth, net margin, ROE, and ROA, supports a positive outlook, despite a high debt-to-equity ratio. The varied analyst opinions indicate a level of uncertainty, but the overall positive financial indicators and updated price targets suggest a likely upward movement in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100